Bank of New York Mellon
DNA icon

Bank of New York Mellon’s Ginkgo Bioworks DNA Stock Holding History

Bank of New York Mellon’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
170,481
+46,522
+38% +$389K ﹤0.01% 3056
2026
Q1 		$760K Buy
123,959
+2,178
+2% +$18.1K ﹤0.01% 3379
2025
Q4 		$1.01M Sell
121,781
-162
-0.1% -$1.74K ﹤0.01% 3230
2025
Q3 		$1.78M Buy
121,943
+3,156
+3% +$37.8K ﹤0.01% 2865
2025
Q2 		$1.34M Buy
118,787
+92,395
+350% +$716K ﹤0.01% 2954
2025
Q1 		$150K Buy
26,392
+3,331
+14% +$33.9K ﹤0.01% 3951
2024
Q4 		$226K Buy
23,061
+7,503
+48% +$64.3K ﹤0.01% 3906
2024
Q3 		$127K Sell
15,558
-3,863
-20% -$38.7K ﹤0.01% 3985
2024
Q2 		$260K Sell
19,421
-76,528
-80% -$2.28M ﹤0.01% 3874
2024
Q1 		$4.45M Sell
95,949
-15,385
-14% -$796K ﹤0.01% 2383
2023
Q4 		$7.53M Buy
111,334
+7,201
+7% +$441K ﹤0.01% 2152
2023
Q3 		$7.54M Buy
104,133
+2,947
+3% +$236K ﹤0.01% 2105
2023
Q2 		$7.53M Buy
101,186
+19,422
+24% +$1.15M ﹤0.01% 2095
2023
Q1 		$4.35M Buy
81,764
+870
+1% +$55.1K ﹤0.01% 2382
2022
Q4 		$5.47M Sell
80,894
-149
-0.2% -$13.7K ﹤0.01% 2297
2022
Q3 		$10.1M Buy
81,043
+7,278
+10% +$867K ﹤0.01% 1898
2022
Q2 		$7.02M Buy
73,765
+61,136
+484% +$7.46M ﹤0.01% 2138
2022
Q1 		$2.04M Sell
12,629
-440
-3% -$85.6K ﹤0.01% 2931
2021
Q4 		$4.34M Buy
+13,069
New +$6.21M ﹤0.01% 2540

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's DNA Position: Q2 2026 in Review

Bank of New York Mellon increased its Ginkgo Bioworks (DNA) stake by 38% in Q2 2026, buying an estimated $389K and bringing the position to 170,481 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

Bank of New York Mellon first reported a position in DNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $10.1M in Q3 2022. 72 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Bank of New York Mellon held 170,481 shares of Ginkgo Bioworks worth $1.69M as of Q2 2026.
  • Bank of New York Mellon bought 46,522 Ginkgo Bioworks shares in Q2 2026, an estimated $389K.
  • Ginkgo Bioworks made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3056 holding.
  • Bank of New York Mellon first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 19 quarters since.
  • Bank of New York Mellon's Ginkgo Bioworks position peaked at $10.1M in Q3 2022.
  • 72 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.